Literature DB >> 18242222

Microbial influences in inflammatory bowel diseases.

R Balfour Sartor1.   

Abstract

The predominantly anaerobic microbiota of the distal ileum and colon contain an extraordinarily complex variety of metabolically active bacteria and fungi that intimately interact with the host's epithelial cells and mucosal immune system. Crohn's disease, ulcerative colitis, and pouchitis are the result of continuous microbial antigenic stimulation of pathogenic immune responses as a consequence of host genetic defects in mucosal barrier function, innate bacterial killing, or immunoregulation. Altered microbial composition and function in inflammatory bowel diseases result in increased immune stimulation, epithelial dysfunction, or enhanced mucosal permeability. Although traditional pathogens probably are not responsible for these disorders, increased virulence of commensal bacterial species, particularly Escherichia coli, enhance their mucosal attachment, invasion, and intracellular persistence, thereby stimulating pathogenic immune responses. Host genetic polymorphisms most likely interact with functional bacterial changes to stimulate aggressive immune responses that lead to chronic tissue injury. Identification of these host and microbial alterations in individual patients should lead to selective targeted interventions that correct underlying abnormalities and induce sustained and predictable therapeutic responses.

Entities:  

Mesh:

Year:  2008        PMID: 18242222     DOI: 10.1053/j.gastro.2007.11.059

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  702 in total

Review 1.  The yin yang of bacterial polysaccharides: lessons learned from B. fragilis PSA.

Authors:  Neeraj K Surana; Dennis L Kasper
Journal:  Immunol Rev       Date:  2012-01       Impact factor: 12.988

2.  Apple flavonoid phloretin inhibits Escherichia coli O157:H7 biofilm formation and ameliorates colon inflammation in rats.

Authors:  Jin-Hyung Lee; Sushil Chandra Regmi; Jung-Ae Kim; Moo Hwan Cho; Hyungdon Yun; Chang-Soo Lee; Jintae Lee
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

3.  Dysregulation of immune homeostasis in autoimmune diseases.

Authors:  Vijay K Kuchroo; Pamela S Ohashi; R Balfour Sartor; Carola G Vinuesa
Journal:  Nat Med       Date:  2012-01-06       Impact factor: 53.440

4.  Efficacy of probiotics for the management of inflammatory bowel disease.

Authors:  R Balfour Sartor
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-09

Review 5.  Influence of host immunoregulatory genes, ER stress and gut microbiota on the shared pathogenesis of inflammatory bowel disease and Type 1 diabetes.

Authors:  Altin Gjymishka; Roxana M Coman; Todd M Brusko; Sarah C Glover
Journal:  Immunotherapy       Date:  2013-12       Impact factor: 4.196

6.  Bifidobacterium animalis causes extensive duodenitis and mild colonic inflammation in monoassociated interleukin-10-deficient mice.

Authors:  James P Moran; Jens Walter; Gerald W Tannock; Susan L Tonkonogy; R Balfour Sartor
Journal:  Inflamm Bowel Dis       Date:  2009-07       Impact factor: 5.325

7.  Ameliorating Active Ulcerative Colitis via an Orally Available Toll-Like Receptor-9 Modifier: A Prospective Open-Label, Multicenter Phase II Trial.

Authors:  Iris Dotan; Etgar Levy-Nissenbaum; Yehuda Chowers; Alexander Fich; Eran Israeli; Tomer Adar; Shimon Shteingart; Hermona Soreq; Eran Goldin
Journal:  Dig Dis Sci       Date:  2016-08-29       Impact factor: 3.199

8.  The epigenetic regulator Uhrf1 facilitates the proliferation and maturation of colonic regulatory T cells.

Authors:  Yuuki Obata; Yukihiro Furusawa; Takaho A Endo; Jafar Sharif; Daisuke Takahashi; Koji Atarashi; Manabu Nakayama; Satoshi Onawa; Yumiko Fujimura; Masumi Takahashi; Tomokatsu Ikawa; Takeshi Otsubo; Yuki I Kawamura; Taeko Dohi; Shoji Tajima; Hiroshi Masumoto; Osamu Ohara; Kenya Honda; Shohei Hori; Hiroshi Ohno; Haruhiko Koseki; Koji Hase
Journal:  Nat Immunol       Date:  2014-04-28       Impact factor: 25.606

Review 9.  Regulation of intestinal microbiota by the NLR protein family.

Authors:  Amlan Biswas; Koichi S Kobayashi
Journal:  Int Immunol       Date:  2013-01-15       Impact factor: 4.823

10.  Host Immune Response to Clostridium difficile Infection in Inflammatory Bowel Disease Patients.

Authors:  Michelle Hughes; Taha Qazi; Adam Berg; Janice Weinberg; Xinhua Chen; Ciaran P Kelly; Francis A Farraye
Journal:  Inflamm Bowel Dis       Date:  2016-04       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.